STEVEN PIERCE: Open Payments
NPI 1184122756 · REXBURG, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,743 in 90 payments from 25 companies in 2025. Trend: 2023 $200 · 2024 $234 · 2025 $1,743
Food & beverage: $1,665Education: $78
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $382 |
| Teva Pharmaceuticals USA, Inc. | 6 | $168 |
| Lilly USA, LLC | 9 | $124 |
| Neurocrine BioSciences, Inc. | 5 | $99 |
| TG Therapeutics, Inc. | 4 | $98 |
| EMD Serono, Inc. | 2 | $86 |
| Biogen, Inc. | 4 | $77 |
| Genentech USA, Inc. | 3 | $70 |
| JAZZ PHARMACEUTICALS INC. | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 4 | $69 |
Products named: QULIPTA, INGREZZA, BRIUMVI, AUSTEDO XR, TYSABRI, XYWAV, KESIMPTA, UBRELVY.
Industry payments across ID — which companies pay providers there.
